Skip to main content

Gone but Not Forgotten: Retracted COVID-19 Papers Still Cited

University of Wollongong epidemiologist Gideon Meyerowitz-Katz speaks with The Scientist about his team’s finding that flawed and fraudulent COVID-19 research continues to be cited.

Written byHannah Thomasy, PhD
| 5 min read
A wire mesh garbage can has toppled over, spilling crumpled papers onto the ground.
Register for free to listen to this article
Listen with Speechify
0:00
5:00

Retraction, a process in which a journal withdraws research after publication, is an essential tool for pruning flawed or fraudulent studies from the scientific literature. But a preprint posted to medRxiv on June 30 shows that retraction may not be functioning as intended: Retracted papers on clinical COVID-19 research have been cited more than 1,000 times, largely uncritically, indicating that conclusions drawn from untrustworthy research may continue to affect the literature and scientists’ understanding of the disease.

Furthermore, many of these citing papers were submitted for publication after the original papers were retracted, raising concerns about authors’ and journals’ standards for citations. Research published in PNAS on June 14 similarly found that most papers that are later retracted have already been widely disseminated on news sites and social media before they’re removed from the record, further fueling worries that the tool is ill-equipped to limit the spread of bad information.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Hannah Thomasy, PhD headshot

    Hannah is an Assistant Editor at The Scientist. Her work has appeared in The New York Times, The Daily Beast, and Undark. She earned her PhD in neuroscience from the University of Washington where she studied traumatic brain injury and sleep. She completed the Dalla Lana Fellowship in Global Journalism in 2020. Outside of work, she enjoys running and aspires to be a participant on The Great Canadian Baking Show.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays